--- title: "Milestone Payment, Definition | MedTech Terms" description: "Contingent payment triggered by a defined event in a partnership, M&A, or financing. Plain-English Investment & Finance definition for MedTech teams, with examp" lang: en json-ld: | { "@context": "https://schema.org", "@graph": [ { "@type": "DefinedTerm", "@id": "https://medtechterms.com/terms/milestone-payment#term", "name": "Milestone Payment", "description": "Milestone payments - common in licensing deals and acquisitions - release capital upon defined regulatory (e.g., PMA approval), clinical (e.g., enrollment), or commercial (e.g., sales thresholds) milestones.", "url": "https://medtechterms.com/terms/milestone-payment", "termCode": "milestone-payment", "inDefinedTermSet": { "@type": "DefinedTermSet", "name": "MedTech Terms", "url": "https://medtechterms.com/terms" } }, { "@type": "Article", "@id": "https://medtechterms.com/terms/milestone-payment#article", "headline": "Milestone Payment", "description": "Contingent payment triggered by a defined event in a partnership, M&A, or financing.", "url": "https://medtechterms.com/terms/milestone-payment", "mainEntityOfPage": { "@type": "WebPage", "@id": "https://medtechterms.com/terms/milestone-payment" }, "about": { "@id": "https://medtechterms.com/terms/milestone-payment#term" }, "articleSection": "Investment & Finance", "inLanguage": "en", "keywords": "Milestone Payment, Investment & Finance, medical device, MedTech", "author": { "@type": "Person", "name": "Christian Espinosa", "jobTitle": "Founder, Blue Goat Cyber", "url": "https://bluegoatcyber.com" }, "publisher": { "@type": "Organization", "name": "MedTech Terms", "url": "https://medtechterms.com" }, "isPartOf": { "@type": "WebSite", "name": "MedTech Terms", "url": "https://medtechterms.com" }, "datePublished": "2026-05-05", "dateModified": "2026-05-05", "citation": [ { "@type": "CreativeWork", "name": "BIO Deal Database", "url": "https://www.bio.org/", "publisher": { "@type": "Organization", "name": "BIO" } }, { "@type": "CreativeWork", "name": "PitchBook - MedTech Coverage", "url": "https://pitchbook.com/news/articles/topic/healthtech", "publisher": { "@type": "Organization", "name": "PitchBook" } }, { "@type": "CreativeWork", "name": "NVCA Model Documents", "url": "https://nvca.org/model-legal-documents/", "publisher": { "@type": "Organization", "name": "NVCA" } } ], "mentions": [ { "@type": "DefinedTerm", "@id": "https://medtechterms.com/terms/tranched-financing#term", "name": "Tranched Financing", "url": "https://medtechterms.com/terms/tranched-financing" }, { "@type": "DefinedTerm", "@id": "https://medtechterms.com/terms/term-sheet#term", "name": "Term Sheet", "url": "https://medtechterms.com/terms/term-sheet" } ] }, { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "Home", "item": "https://medtechterms.com/" }, { "@type": "ListItem", "position": 2, "name": "Terms", "item": "https://medtechterms.com/terms" }, { "@type": "ListItem", "position": 3, "name": "Investment & Finance", "item": "https://medtechterms.com/terms?cat=Investment%20%26%20Finance" }, { "@type": "ListItem", "position": 4, "name": "Milestone Payment", "item": "https://medtechterms.com/terms/milestone-payment" } ] }, { "@type": "FAQPage", "@id": "https://medtechterms.com/terms/milestone-payment#faq", "mainEntity": [ { "@type": "Question", "name": "How do regulatory milestones differ from clinical milestones?", "acceptedAnswer": { "@type": "Answer", "text": "Regulatory milestones are tied to approvals or clearances from authorities like the FDA or a Notified Body, while clinical milestones relate to progress in human studies, such as patient enrollment completion or successful interim trial results." } }, { "@type": "Question", "name": "Can cybersecurity-related achievements be milestone triggers?", "acceptedAnswer": { "@type": "Answer", "text": "Yes, increasingly, demonstrating compliance with cybersecurity requirements, such as achieving specific security certifications or successfully completing cybersecurity vulnerability assessments, could be defined as a milestone, especially for connected medical devices." } }, { "@type": "Question", "name": "What happens if a regulatory milestone is delayed?", "acceptedAnswer": { "@type": "Answer", "text": "If a regulatory milestone is delayed, the associated payment will also be deferred, potentially impacting the financial projections and liquidity of the recipient party, underscoring the importance of realistic regulatory timelines." } } ] } ] } --- [ MedTech Terms The authoritative reference ](/) Browse Learn [Latest](/latest) About 1. [Home](/) 2. / 3. [Terms](/terms) 4. / 5. [Investment & Finance](/terms?cat=Investment%20%26%20Finance) 6. / 7. Milestone Payment [All terms](/terms) Investment & Finance [Startup Lifecycle](/ecosystems/startup-lifecycle) # Milestone Payment Contingent payment triggered by a defined event in a partnership, M&A, or financing. Reviewed by [Christian Espinosa, Founder, Blue Goat Cyber](/authors/christian-espinosa) Last reviewed May 5, 2026 ## Definition Milestone payments - common in licensing deals and acquisitions - release capital upon defined regulatory (e.g., [PMA](/terms/pma) approval), clinical (e.g., enrollment), or commercial (e.g., sales thresholds) milestones. What the regulation says While milestone payments are primarily a financial construct, regulatory approvals are frequently designated as milestones. For example, a payment might be contingent upon obtaining a 510(k) clearance or a [Premarket Approval](/terms/pma) (PMA) from the FDA, or a [CE Mark](/terms/ce-mark) under the [EU Medical Device Regulation](/terms/mdr) (EU [MDR](/terms/mdr-reporting)). These regulatory achievements directly impact a MedTech product's market access and commercial viability, thus serving as critical junctures for financial disbursements in agreements. ## What this means in practice Deal value often hinges on milestone structure: heavy back-end milestones reduce upfront risk for the acquirer but defer founder/investor proceeds. ## Examples - A licensing agreement stipulates a $10 million payment to the licensor upon the FDA granting Premarket Approval (PMA) for the licensed Class III diagnostic device. - An acquisition deal includes a clause for an additional $5 million to the acquired company's founders once their novel robotic surgical system receives a CE Mark under the EU MDR, allowing it to be marketed in Europe. - A development contract specifies a payment upon successful submission of a 510(k) premarket notification to the FDA for a new medical imaging device, demonstrating progress toward market authorization. Common pitfalls - • Misinterpreting regulatory milestones can lead to significant financial and project timeline discrepancies. - • Failing to clearly define the exact regulatory event triggering a payment can result in disputes between parties. - • Overlooking the potential for regulatory delays to impact milestone payment schedules is a common mistake. - • Assuming regulatory submissions alone, rather than final approvals, constitute a payment milestone can create confusion. ## Frequently asked questions How do regulatory milestones differ from clinical milestones? Regulatory milestones are tied to approvals or clearances from authorities like the FDA or a [Notified Body](/terms/notified-body), while clinical milestones relate to progress in human studies, such as patient enrollment completion or successful interim trial results. Can cybersecurity-related achievements be milestone triggers? What happens if a regulatory milestone is delayed? ## Cross-references ### Used by Things that build on this term. - [ Tranched Financing ](/terms/tranched-financing) ## Related terms Grouped by theme ### Editor's picks · Hand-selected related concepts [ Investment & Finance Term Sheet Non-binding outline of the key economic and control terms of an investment. ](/terms/term-sheet)[ Investment & Finance Tranched Financing Financing committed in stages tied to predefined milestones. ](/terms/tranched-financing) ### More in Investment & Finance · Same category [ Investment & Finance 409A Valuation An independent fair-market-value appraisal of common stock used to set tax-compliant strike prices for employee stock options. ](/terms/409a-valuation)[ Investment & Finance Anti-Dilution Protection Adjustment that protects investors if the company raises a future round at a lower price. ](/terms/anti-dilution)[ Investment & Finance Bridge Round Interim financing between priced rounds, usually convertible. ](/terms/bridge-round)[ Investment & Finance Burn Rate Rate at which a company spends cash, typically expressed monthly. ](/terms/burn-rate) Cited by Where this term appears across MedTech Terms. Ecosystems (1) - [Startup Lifecycle](/ecosystems/startup-lifecycle) ## Primary references 3 sources Link health: 3 verified · last checked 2026-06-20 BIO· 1 PitchBook· 1 NVCA· 1 1. [1 BIO Deal Database Verified BIO · bio.org ](https://www.bio.org/) 2. [2 PitchBook - MedTech Coverage Verified PitchBook · pitchbook.com ](https://pitchbook.com/news/articles/topic/healthtech) 3. [3 NVCA Model Documents Verified NVCA · nvca.org ](https://nvca.org/model-legal-documents/) Inline markers like \[1\] jump to the matching reference above. Sponsor note ### Diligencing a MedTech cybersecurity posture? Blue Goat Cyber supports investors and acquirers with cybersecurity diligence on connected MedTech assets. [Book a 30-minute discovery session](https://go.bluegoatcyber.com/meetings/blue-goat-cyber/discovery-session) - No obligation - Expert-led from minute one - NDA available on request MedTech Terms is a community resource sponsored by [Blue Goat Cyber](https://bluegoatcyber.com). Definitions are independent of any vendor. On this term Category Investment & Finance Sources 3 Updated 5/5/2026 [Compare with another term](/compare?a=milestone-payment) Learn in 60 seconds Card Lesson Quiz Contingent payment triggered by a defined event in a partnership, M&A, or financing. - · Deal value often hinges on milestone structure: heavy back-end milestones reduce upfront risk for the acquirer but defer founder/investor proceeds. Remember this Watch out: Misinterpreting regulatory milestones can lead to significant financial and project timeline discrepancies. Related terms - [Tranched Financing ](/terms/tranched-financing) - [Term Sheet ](/terms/term-sheet) You may also need Auto-suggested from Investment & Finance and shared keywords. - [Earn-Out ](/terms/earn-out) - [Milestone-Based Tranche ](/terms/milestone-tranche) - [Due Diligence ](/terms/due-diligence) - [Mergers and Acquisitions(M&A) ](/terms/m-and-a) - [Non-Dilutive Funding ](/terms/non-dilutive-funding) - [Series A / B / C Financing Rounds ](/terms/series-funding) [All Investment & Finance terms](/terms?cat=Investment%20%26%20Finance) MedTech Terms An authoritative, plain-language reference for the regulatory, quality, cybersecurity, and software terms that shape modern medical devices. Browse - [All terms](/terms) - [A–Z index](/a-z) - [Categories](/categories) - [Ecosystems](/ecosystems) - [Learning paths](/paths) - [Compare terms](/compare) - [Quiz](/quiz) Resources - [FDA Medical Devices](https://www.fda.gov/medical-devices) - [EU MDR](https://eur-lex.europa.eu/eli/reg/2017/745/oj) - [IMDRF](https://www.imdrf.org/) - [Methodology](/methodology) - [Changelog](/changelog) - [Editor: Christian Espinosa](/authors/christian-espinosa) - [About this site](/about) © 2026 MedTech Terms. Reference content for educational purposes - not regulatory advice. A community resource sponsored by [Blue Goat Cyber](https://bluegoatcyber.com)